DaicelDAICEL CORPORATION4202東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
About 42% of Daicel's sales come from Engineering Plastics, with Materials and Safety making up much of the rest.
Out of every ¥100 of sales, about ¥10 is left as operating profit.
Revenue changed +5.1% from the prior year, operating profit -2.2%.
Revenue +5.1% · profit -2.2%, calculated from disclosed figures.
Operating leverage: -0.43× (profit growth ÷ revenue growth)
FY ending Mar 2024 → FY ending Mar 2025
FY ending Mar 2024 → FY ending Mar 2025
For every ¥100 Daicel sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第160期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第159期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第158期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第157期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
訂正有価証券報告書-第156期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第155期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 56 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.